キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/12/03 | 3,675 | 3,760 | 3,675 | 3,725 | +25 | +0.7% | 71,800 |
2024/12/02 | 3,635 | 3,730 | 3,635 | 3,700 | +55 | +1.5% | 81,900 |
2024/11/29 | 3,640 | 3,670 | 3,605 | 3,645 | +35 | +1% | 45,900 |
2024/11/28 | 3,590 | 3,630 | 3,545 | 3,610 | -20 | -0.6% | 58,400 |
2024/11/27 | 3,670 | 3,670 | 3,580 | 3,630 | -55 | -1.5% | 48,700 |
2024/11/26 | 3,655 | 3,685 | 3,620 | 3,685 | +85 | +2.4% | 54,500 |
2024/11/25 | 3,695 | 3,725 | 3,545 | 3,600 | -55 | -1.5% | 167,700 |
2024/11/22 | 3,680 | 3,725 | 3,625 | 3,655 | -35 | -0.9% | 48,300 |
2024/11/21 | 3,700 | 3,730 | 3,670 | 3,690 | -15 | -0.4% | 36,900 |
2024/11/20 | 3,625 | 3,705 | 3,625 | 3,705 | +80 | +2.2% | 45,700 |
2024/11/19 | 3,645 | 3,675 | 3,615 | 3,625 | ±0 | ±0% | 37,100 |
2024/11/18 | 3,580 | 3,650 | 3,540 | 3,625 | -25 | -0.7% | 62,300 |
2024/11/15 | 3,710 | 3,710 | 3,640 | 3,650 | -40 | -1.1% | 32,900 |
2024/11/14 | 3,700 | 3,740 | 3,680 | 3,690 | -25 | -0.7% | 38,100 |
2024/11/13 | 3,710 | 3,740 | 3,690 | 3,715 | +20 | +0.5% | 54,100 |
2024/11/12 | 3,680 | 3,730 | 3,680 | 3,695 | +45 | +1.2% | 53,300 |
2024/11/11 | 3,640 | 3,670 | 3,605 | 3,650 | -10 | -0.3% | 77,100 |
2024/11/08 | 3,685 | 3,715 | 3,610 | 3,660 | -30 | -0.8% | 78,200 |
2024/11/07 | 3,710 | 3,770 | 3,670 | 3,690 | +5 | +0.1% | 121,500 |
2024/11/06 | 3,780 | 3,810 | 3,650 | 3,685 | -95 | -2.5% | 141,600 |
2024/11/05 | 3,715 | 3,780 | 3,690 | 3,780 | +30 | +0.8% | 66,100 |
2024/11/01 | 3,700 | 3,790 | 3,695 | 3,750 | +10 | +0.3% | 48,700 |
2024/10/31 | 3,740 | 3,770 | 3,700 | 3,740 | +25 | +0.7% | 78,900 |
2024/10/30 | 3,705 | 3,740 | 3,690 | 3,715 | +15 | +0.4% | 105,800 |
2024/10/29 | 3,670 | 3,715 | 3,660 | 3,700 | -5 | -0.1% | 43,400 |
2024/10/28 | 3,670 | 3,725 | 3,665 | 3,705 | +20 | +0.5% | 46,200 |
2024/10/25 | 3,750 | 3,760 | 3,675 | 3,685 | -65 | -1.7% | 47,500 |
2024/10/24 | 3,740 | 3,760 | 3,705 | 3,750 | -5 | -0.1% | 62,300 |
2024/10/23 | 3,780 | 3,820 | 3,755 | 3,755 | -25 | -0.7% | 52,700 |
2024/10/22 | 3,830 | 3,830 | 3,775 | 3,780 | -55 | -1.4% | 54,000 |
2024/10/21 | 3,850 | 3,865 | 3,830 | 3,835 | -15 | -0.4% | 59,200 |
2024/10/18 | 3,850 | 3,910 | 3,850 | 3,850 | +35 | +0.9% | 71,700 |
2024/10/17 | 3,790 | 3,830 | 3,790 | 3,815 | +30 | +0.8% | 56,600 |
2024/10/16 | 3,755 | 3,830 | 3,755 | 3,785 | +5 | +0.1% | 54,000 |
2024/10/15 | 3,785 | 3,810 | 3,770 | 3,780 | +20 | +0.5% | 57,800 |
2024/10/11 | 3,720 | 3,760 | 3,710 | 3,760 | +10 | +0.3% | 75,700 |
2024/10/10 | 3,725 | 3,750 | 3,715 | 3,750 | +25 | +0.7% | 69,600 |
2024/10/09 | 3,700 | 3,730 | 3,675 | 3,725 | +25 | +0.7% | 71,800 |
2024/10/08 | 3,710 | 3,765 | 3,680 | 3,700 | -80 | -2.1% | 65,100 |
2024/10/07 | 3,700 | 3,785 | 3,660 | 3,780 | +80 | +2.2% | 107,300 |
2024/10/04 | 3,640 | 3,735 | 3,640 | 3,700 | +45 | +1.2% | 81,900 |
2024/10/03 | 3,630 | 3,670 | 3,585 | 3,655 | +95 | +2.7% | 123,000 |
2024/10/02 | 3,610 | 3,625 | 3,550 | 3,560 | -50 | -1.4% | 60,700 |
2024/10/01 | 3,545 | 3,615 | 3,540 | 3,610 | +65 | +1.8% | 52,500 |
2024/09/30 | 3,510 | 3,570 | 3,485 | 3,545 | -25 | -0.7% | 76,100 |
2024/09/27 | 3,540 | 3,610 | 3,525 | 3,570 | -45 | -1.2% | 97,700 |
2024/09/26 | 3,560 | 3,620 | 3,560 | 3,615 | +80 | +2.3% | 102,100 |
2024/09/25 | 3,535 | 3,555 | 3,500 | 3,535 | ±0 | ±0% | 52,400 |
2024/09/24 | 3,515 | 3,545 | 3,470 | 3,535 | +45 | +1.3% | 54,300 |
2024/09/20 | 3,535 | 3,565 | 3,465 | 3,490 | -5 | -0.1% | 105,200 |
101~
150
件表示中 / 3693件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 381,000円 | +14.5% | -2.3% | 2.36% | 13.94倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サワイGHD | 201,600円 | +4.0% | +25.4% | 2.63% | 8.82倍 | 1.16倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
科研薬 | 405,500円 | +30.5% | +111.0% | 4.69% | 11.43倍 | 0.99倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
サンバイオ | 231,700円 | - | - | 0.00% | - | 107.32倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
鳥居薬 | 558,000円 | +7.1% | -35.0% | 2.15% | 46.14倍 | 1.29倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム